Clinical Trials Directory

Trials / Completed

CompletedNCT04962035

Neurocognitive Follow-Up (FU) Study

Neurocognitive Scores of Predominantly Formula Fed Preterm Infants in Early Childhood Years

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
17 Months – 25 Months
Healthy volunteers
Accepted

Summary

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).

Detailed description

This is a follow-up study of a recently completed multi-center, prospective, single-arm, open-label interventional trial (17.14.INF - Alprem RTF: NCT03728764) evaluating the growth of pre-term infants receiving a two-stage PTF feeding system while in the neonatal care unit and continuing until 30 days post-discharge. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA). The timing of the cognitive assessments aligns with routine check-up visits and reflect the period at which developmental delays may first become evident.

Conditions

Interventions

TypeNameDescription
OTHERNeurocognitive Follow-upStandard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions.

Timeline

Start date
2021-03-26
Primary completion
2021-11-30
Completion
2021-12-22
First posted
2021-07-14
Last updated
2023-03-24

Locations

3 sites across 2 countries: Poland, Slovakia

Source: ClinicalTrials.gov record NCT04962035. Inclusion in this directory is not an endorsement.